IBD Library
Welcome to the IBD Library, a comprehensive collection of curated research and evidence in the field of IBD. Here, you’ll find a diverse range of studies, including systematic reviews, meta-analyses and more. Dive into the carefully organized repository to explore the latest insights, robust evidence, and scholarly resources that contribute to a deeper understanding of IBD management and treatment.
Network meta-analysis
2023 onset of effect biologics & small molecules UC
2023 biologics in UC
2023 Efficacy & safety of biologics & small molecules UC
2023 Efficacy of biologics & small molecules in CD
2022 Efficacy & safety Biologics & small molecules UC
2021 Efficacy of Biologics in CD
2021 Efficacy of Biologics & small molecules UC
2021 5ASA oral, topical or combined in UC
2021 First & second line therapy in UC
2018 First & second line therapy in CD
2017 Mesalamine, Sulfasalazine, Corticosteroids & Budesonide in CD
2015 Immunosupressants & biologics in CD
2015 Budesonide & mesalazine in CD
Cochrane Database of Systematic Reviews
2023 Vitamin D for the treatment of inflammatory bowel disease
2023 Vedolizumab for induction and maintenance of remission in Crohn's disease
2023 Patient education Interventions for the management of IBD
2023 Remote care through telehealth for people with IBD
2022 Stem cell transplantation for induction of remission in medically refractory CD
2021 Interventions for iron deficiency anemia in IBD
2020 Interventions for fatigue in IBD
2020 JAK inhibitors for maintenance of remission in UC
2020 Risk of postoperative infectious complications from medical therapies in IBD
2020 Oral 5ASA for maintenance of remission in UC
2020 Probiotics for induction of remission in UC
2020 Probiotics for maintenance of remission in UC
2020 Probiotics for induction of remission in CD
2020 Adalimumab for maintenance of remission in CD
2019 Anti-IL-12/23p40 antibodies for maintenance of remission in CD
2019 Interventions for maintenance of surgically induced remission in CD
2019 Adalimumab for induction of remission in CD
2019 Certolizumab peg for induction of remission in CD
2019 Treatment & prevention of pouchitis after IPAA in UC
2019 Dietary interventions for induction & maintenance of remission in IBD
2019 Antibiotics for induction and maintenance of remission in CD
2019 AZA and MP for maintenance of surgically‐induced remission in CD
2018 Cannabis for the treatment of CD
2018 Natalizumab for induction of remission in CD
2018 Withdrawal of immunosuppressant or biologic therapy for patients with quiescent CD
2018 Enteral nutritional for induction of remission in CD
2018 Low dose naltrexone for induction of remission in CD
2018 Fecal transplantation for the treatment of IBD
2017 Histologic scoring indices for evaluation of activity in CD
2017 Placebo response and remission rates in RCTs of induction & maintenance therapy in UC
2016 Anti-IL-12/23p40 antibodies for induction of remission in CD
2016 AZA or MP for induction of remission in CD
2016 Aminosalicylates for induction of remission/response in CD
2016 Anti-tuberculous therapy for maintenance of remission in CD
2016 AZA and MP for maintenance of remission in UC
2015 AZA & MP for maintenance of remission in CD
2015 Budesonide for induction of remission in CD
2015 impact of biological interventions for UC on health-related QoL
2015 Type I interferons induction of remission in UC
2015 MTX for maintenance of remission in UC
2015 VDZ for induction & maintenance of remission in UC
2015 Oral budesonide for induction of remission in UC
2015 Etrolizumab for induction of remission in UC
2014 Budesonide for maintenance of remission in CD
2014 MTX for induction of remission in UC
2014 MTX for maintenance of remission in CD
2014 MTX for induction of remission in CD
2014 Helminth therapy (worms) for induction of remission in IBD
2014 Omega 3 fatty acids (fish oil) for maintenance of remission in CD
2012 Rectal 5-ASA for induction of remission in UC
2011 Laparoscopic vs Open surgery for small bowel CD
2011 Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in CD
2011 Sargramostim (GM-CSF) for induction of remission in CD
2011 Psychological interventions for treatment of IBD
2010 Recombinant human interleukin 10 for induction of remission in CD
2010 Unfractionated or low‐molecular weight heparin for induction of remission in UC
2009 Open versus laparoscopic (assisted) IPAA in UC & FAP
2009 Interventions for prevention of post-operative recurrence of CD
2008 TNF‐alpha antibody for maintenance of remission in CD
2008 Traditional corticosteroids for induction of remission in CD
2007 Enteral nutrition for maintenance of remission in CD
2007 Omega-3 fatty acids for maintenance of remission in UC
2006 TNF alfa blocking agents for induction of remission in UC
2005 Cyclosporine for induction of remission in CD
2004 Transdermal nicotine for induction remission in UC
Cochrane Database of Systematic Reviews
Any suggestions?
If you have any suggestion of trials or studies to add, changes or corrections of any error, feel free to write me here
Website designed by IbonDesign
Illustrations by Cristina Gros Content creator and development Beatriz Gros
Illustrations by Cristina Gros Content creator and development Beatriz Gros
